{"nct_id":"NCT06280716","title":"A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2024-04-24","start_date_type":"ACTUAL","primary_completion_date":"2025-09","primary_completion_date_type":"ESTIMATED","completion_date":"2026-08","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["LLY"]}